4.4 Article

Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Serum zonulin and claudin-5 levels in patients with schizophrenia

Ayse Usta et al.

Summary: The research aimed to assess serum zonulin and claudin-5 levels in schizophrenia patients, finding that zonulin was increased and claudin-5 was decreased compared to healthy controls. This suggests a potential link between the dysregulation of intestinal permeability and blood-brain barrier and the etiology of schizophrenia.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

Article Neurosciences

Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?

Tongtong Zhao et al.

Summary: This study found evidence that clozapine has a regulatory effect on immune-related proinflammatory cytokines and influences glycometabolism indicators, both in animal experiments and clinical trials. Clozapine-treated patients showed significant increases in blood glucose, BMI, and proinflammatory cytokines, with higher dosages associated with higher cytokine levels. Positive correlations were observed between blood glucose levels and proinflammatory cytokines.

PSYCHOPHARMACOLOGY (2021)

Review Medicine, General & Internal

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis

Piotr Marcinowicz et al.

Summary: The study shows that antipsychotic treatment leads to decreased concentrations of certain pro-inflammatory and anti-inflammatory cytokines in FEP patients, while leaving levels of other cytokines unaffected. Comparing with other meta-analyses involving schizophrenic subjects, the results are consistent in some cytokines but indicate a decrease in anti-inflammatory IL-10 in FEP patients after antipsychotic treatment.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Clinical Neurology

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics

Xinyu Fang et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)

Article Clinical Neurology

Role of cytokine changes in clozapine-induced fever: A cohort prospective study

Yuan-Pin Hung et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)

Article Psychiatry

Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia

Theresa Wimberley et al.

AMERICAN JOURNAL OF PSYCHIATRY (2017)

Review Clinical Neurology

Worldwide Differences in Regulations of Clozapine Use

Jimmi Nielsen et al.

CNS DRUGS (2016)

Editorial Material Psychiatry

The Role of Clozapine in Treatment-Resistant Schizophrenia

John M. Kane et al.

JAMA PSYCHIATRY (2016)

Article Pharmacology & Pharmacy

Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia

Alp Ucok et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2015)

Article Psychiatry

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

Jari-Pekka Klemettila et al.

PSYCHIATRY RESEARCH (2014)

Article Pharmacology & Pharmacy

Use of Clozapine for the Treatment of Schizophrenia: Findings of the 2006 Research on the China Psychotropic Prescription Studies

Tian-Mei Si et al.

Clinical Psychopharmacology and Neuroscience (2012)

Review Neurosciences

Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review

Stephane Potvin et al.

BIOLOGICAL PSYCHIATRY (2008)

Review Pharmacology & Pharmacy

Clozapine in China

Y. -I Tang et al.

PHARMACOPSYCHIATRY (2008)

Article Clinical Neurology

Clinical correlates of clozapine prescription for schizophrenia in China

Yu-tao Xiang et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2007)